Total submissions: 20
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000202489 | SCV002540676 | benign | Rett syndrome | 2022-05-10 | reviewed by expert panel | curation | The allele frequency of the p.Ala201Val (NM_004992) variant in MECP2 is 1.045% in East Asian sub population in gnomAD, which is high enough to be classified as Benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BA1). In summary, the p.Ala201Val variant in MECP2 is classified as Benign based on the ACMG/AMP criteria (BA1). |
Gene |
RCV000153477 | SCV000170220 | benign | not specified | 2016-06-17 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000153477 | SCV000202984 | benign | not specified | 2014-04-15 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000153477 | SCV000247981 | benign | not specified | 2013-06-05 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000224215 | SCV000281574 | benign | not provided | 2015-02-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001083234 | SCV000556752 | benign | Severe neonatal-onset encephalopathy with microcephaly | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genomic Research Center, |
RCV000202489 | SCV000746807 | likely benign | Rett syndrome | 2017-12-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000717310 | SCV000848159 | benign | History of neurodevelopmental disorder | 2016-07-07 | criteria provided, single submitter | clinical testing | Co-occurence with a mutation in another gene that clearly explains a proband's phenotype;Co-occurence with mutation in same gene (phase unknown);Does not segregate with disease in family study (genes with incomplete penetrance);In silico models in agreement (benign);Subpopulation frequency in support of benign classification |
Institute of Human Genetics, |
RCV001083234 | SCV001440877 | benign | Severe neonatal-onset encephalopathy with microcephaly | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002498620 | SCV002797283 | likely benign | Severe neonatal-onset encephalopathy with microcephaly; Syndromic X-linked intellectual disability Lubs type; X-linked intellectual disability-psychosis-macroorchidism syndrome; Rett syndrome; Autism, susceptibility to, X-linked 3 | 2022-04-25 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000224215 | SCV004220015 | benign | not provided | 2023-06-12 | criteria provided, single submitter | clinical testing | |
Centre for Population Genomics, |
RCV000202489 | SCV004808874 | benign | Rett syndrome | 2024-03-22 | criteria provided, single submitter | curation | This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as benign. At least the following criteria are met: The allele frequency of this variant in at least one population in gnomAD is higher than the 0.03% threshold defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders VCEP 3.0 (BA1). |
Victorian Clinical Genetics Services, |
RCV001083234 | SCV005086733 | benign | Severe neonatal-onset encephalopathy with microcephaly | 2023-07-17 | criteria provided, single submitter | clinical testing | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Benign. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with Encephalopathy, neonatal severe (MIM#300673). (I) 0109 - This gene is associated with X-linked recessive disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from alanine to valine. (I) 0251 - This variant is heterozygous. (I) 0308 - Population frequency for this variant is out of keeping with known incidence of disease. (SB) 0502 - Missense variant with conflicting in silico predictions and uninformative conservation. (I) 0805 - This variant has strong previous evidence of being benign in unrelated individuals. (SB) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign |
Breakthrough Genomics, |
RCV000224215 | SCV005206921 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Rett |
RCV000153477 | SCV000188167 | benign | not specified | 2013-06-12 | no assertion criteria provided | curation | |
Clinical Molecular Genetics Laboratory, |
RCV000202489 | SCV000257513 | pathogenic | Rett syndrome | 2012-08-17 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV000224215 | SCV001744278 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000224215 | SCV001800252 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000153477 | SCV001929517 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000224215 | SCV001972809 | likely benign | not provided | no assertion criteria provided | clinical testing |